vs

Side-by-side financial comparison of AbbVie (ABBV) and Netflix (NFLX). Click either name above to swap in a different company.

AbbVie is the larger business by last-quarter revenue ($15.0B vs $12.2B, roughly 1.2× Netflix). Netflix runs the higher net margin — 43.1% vs 4.6%, a 38.5% gap on every dollar of revenue. On growth, Netflix posted the faster year-over-year revenue change (16.2% vs 9.9%). Over the past eight quarters, Netflix's revenue compounded faster (13.2% CAGR vs 1.8%).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Netflix is an American subscription video on-demand over-the-top streaming service. The service primarily distributes original and acquired films and television shows from various genres. It is available internationally in multiple languages.

ABBV vs NFLX — Head-to-Head

Bigger by revenue
ABBV
ABBV
1.2× larger
ABBV
$15.0B
$12.2B
NFLX
Growing faster (revenue YoY)
NFLX
NFLX
+6.3% gap
NFLX
16.2%
9.9%
ABBV
Higher net margin
NFLX
NFLX
38.5% more per $
NFLX
43.1%
4.6%
ABBV
Faster 2-yr revenue CAGR
NFLX
NFLX
Annualised
NFLX
13.2%
1.8%
ABBV

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ABBV
ABBV
NFLX
NFLX
Revenue
$15.0B
$12.2B
Net Profit
$697.0M
$5.3B
Gross Margin
51.9%
Operating Margin
26.6%
32.3%
Net Margin
4.6%
43.1%
Revenue YoY
9.9%
16.2%
Net Profit YoY
-46.0%
82.8%
EPS (diluted)
$0.39
$1.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABBV
ABBV
NFLX
NFLX
Q1 26
$15.0B
$12.2B
Q4 25
$16.6B
$12.1B
Q3 25
$15.8B
$11.5B
Q2 25
$15.4B
$11.1B
Q1 25
$13.3B
$10.5B
Q4 24
$15.1B
$10.2B
Q3 24
$14.5B
$9.8B
Q2 24
$14.5B
$9.6B
Net Profit
ABBV
ABBV
NFLX
NFLX
Q1 26
$697.0M
$5.3B
Q4 25
$1.8B
$2.4B
Q3 25
$186.0M
$2.5B
Q2 25
$938.0M
$3.1B
Q1 25
$1.3B
$2.9B
Q4 24
$-22.0M
$1.9B
Q3 24
$1.6B
$2.4B
Q2 24
$1.4B
$2.1B
Gross Margin
ABBV
ABBV
NFLX
NFLX
Q1 26
51.9%
Q4 25
72.6%
45.9%
Q3 25
66.4%
46.4%
Q2 25
71.8%
51.9%
Q1 25
70.0%
50.1%
Q4 24
70.9%
43.7%
Q3 24
70.9%
47.9%
Q2 24
70.9%
45.9%
Operating Margin
ABBV
ABBV
NFLX
NFLX
Q1 26
26.6%
32.3%
Q4 25
27.3%
24.5%
Q3 25
12.1%
28.2%
Q2 25
31.7%
34.1%
Q1 25
28.0%
31.7%
Q4 24
-9.9%
22.2%
Q3 24
26.5%
29.6%
Q2 24
27.6%
27.2%
Net Margin
ABBV
ABBV
NFLX
NFLX
Q1 26
4.6%
43.1%
Q4 25
10.9%
20.1%
Q3 25
1.2%
22.1%
Q2 25
6.1%
28.2%
Q1 25
9.6%
27.4%
Q4 24
-0.1%
18.2%
Q3 24
10.8%
24.1%
Q2 24
9.5%
22.5%
EPS (diluted)
ABBV
ABBV
NFLX
NFLX
Q1 26
$0.39
$1.23
Q4 25
$1.02
$-17.14
Q3 25
$0.10
$5.87
Q2 25
$0.52
$7.19
Q1 25
$0.72
$0.66
Q4 24
$-0.03
$4.27
Q3 24
$0.88
$5.40
Q2 24
$0.77
$4.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABBV
ABBV
NFLX
NFLX
Cash + ST InvestmentsLiquidity on hand
$12.3B
Total DebtLower is stronger
$13.4B
Stockholders' EquityBook value
$31.1B
Total Assets
$61.0B
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABBV
ABBV
NFLX
NFLX
Q1 26
$12.3B
Q4 25
$5.3B
$9.1B
Q3 25
$5.7B
$9.3B
Q2 25
$6.5B
$8.4B
Q1 25
$5.2B
$8.4B
Q4 24
$5.6B
$9.6B
Q3 24
$7.3B
$9.2B
Q2 24
$13.2B
$6.7B
Total Debt
ABBV
ABBV
NFLX
NFLX
Q1 26
$13.4B
Q4 25
$58.9B
$13.5B
Q3 25
$63.0B
$14.5B
Q2 25
$63.0B
$14.5B
Q1 25
$64.5B
$14.0B
Q4 24
$60.3B
$13.8B
Q3 24
$58.5B
$14.2B
Q2 24
$58.0B
$12.2B
Stockholders' Equity
ABBV
ABBV
NFLX
NFLX
Q1 26
$31.1B
Q4 25
$-3.3B
$26.6B
Q3 25
$-2.6B
$26.0B
Q2 25
$-183.0M
$25.0B
Q1 25
$1.4B
$24.0B
Q4 24
$3.3B
$24.7B
Q3 24
$6.0B
$22.7B
Q2 24
$6.8B
$22.1B
Total Assets
ABBV
ABBV
NFLX
NFLX
Q1 26
$61.0B
Q4 25
$134.0B
$55.6B
Q3 25
$133.9B
$54.9B
Q2 25
$137.2B
$53.1B
Q1 25
$136.2B
$52.1B
Q4 24
$135.2B
$53.6B
Q3 24
$143.4B
$52.3B
Q2 24
$141.9B
$49.1B
Debt / Equity
ABBV
ABBV
NFLX
NFLX
Q1 26
0.43×
Q4 25
0.51×
Q3 25
0.56×
Q2 25
0.58×
Q1 25
45.44×
0.58×
Q4 24
18.15×
0.56×
Q3 24
9.70×
0.62×
Q2 24
8.56×
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABBV
ABBV
NFLX
NFLX
Operating Cash FlowLast quarter
$5.3B
Free Cash FlowOCF − Capex
$5.1B
FCF MarginFCF / Revenue
41.6%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
1.00×
TTM Free Cash FlowTrailing 4 quarters
$11.9B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABBV
ABBV
NFLX
NFLX
Q1 26
$5.3B
Q4 25
$5.2B
$2.1B
Q3 25
$7.0B
$2.8B
Q2 25
$5.2B
$2.4B
Q1 25
$1.6B
$2.8B
Q4 24
$7.0B
$1.5B
Q3 24
$5.4B
$2.3B
Q2 24
$2.3B
$1.3B
Free Cash Flow
ABBV
ABBV
NFLX
NFLX
Q1 26
$5.1B
Q4 25
$4.9B
$1.9B
Q3 25
$6.6B
$2.7B
Q2 25
$4.9B
$2.3B
Q1 25
$1.4B
$2.7B
Q4 24
$6.8B
$1.4B
Q3 24
$5.2B
$2.2B
Q2 24
$2.0B
$1.2B
FCF Margin
ABBV
ABBV
NFLX
NFLX
Q1 26
41.6%
Q4 25
29.4%
15.5%
Q3 25
42.1%
23.1%
Q2 25
31.7%
20.5%
Q1 25
10.5%
25.2%
Q4 24
44.7%
13.5%
Q3 24
35.9%
22.3%
Q2 24
14.0%
12.7%
Capex Intensity
ABBV
ABBV
NFLX
NFLX
Q1 26
1.6%
Q4 25
2.0%
2.0%
Q3 25
2.4%
1.4%
Q2 25
1.7%
1.4%
Q1 25
1.8%
1.2%
Q4 24
1.9%
1.5%
Q3 24
1.7%
1.3%
Q2 24
1.7%
0.8%
Cash Conversion
ABBV
ABBV
NFLX
NFLX
Q1 26
1.00×
Q4 25
2.87×
0.87×
Q3 25
37.76×
1.11×
Q2 25
5.49×
0.78×
Q1 25
1.27×
0.97×
Q4 24
0.82×
Q3 24
3.49×
0.98×
Q2 24
1.66×
0.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons